Synovics Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	Current	FY 2008	FY 2007	FY 2006	FY 2005	FY 2004	2003 - 1999
Period Ending	Jan '26 Jan 29, 2026	Oct '08 Oct 31, 2008	Oct '07 Oct 31, 2007	Oct '06 Oct 31, 2006	Oct '05 Oct 31, 2005	Oct '04 Oct 31, 2004	2003 - 1999
Market Capitalization	0	9	24	52	52	3	Upgrade
Market Cap Growth	-99.76%	-61.97%	-54.36%	0.20%	1544.79%	190.45%	Upgrade
Enterprise Value	-	18	42	66	54	5	Upgrade
Last Close Price	0.00	0.35	0.80	2.00	2.30	0.20	Upgrade
PS Ratio	0.00	0.35	1.01	4.95	6345.70	32.00	Upgrade
PB Ratio	0.00	1.81	-2.93	3.98	4.60	-3.49	Upgrade
P/FCF Ratio	0.00	2.87	-	-	-	-	Upgrade
P/OCF Ratio	0.00	2.34	-	-	-	-	Upgrade
EV/Sales Ratio	-	0.70	1.80	6.29	6610.76	54.28	Upgrade
EV/FCF Ratio	-	5.76	-	-	-	-	Upgrade
Debt / Equity Ratio	-7.95	1.31	-2.32	1.36	0.25	-1.64	Upgrade
Debt / FCF Ratio	3.46	2.08	-	-	-	-	Upgrade
Net Debt / Equity Ratio	-7.78	1.30	-2.32	1.18	0.24	-0.94	Upgrade
Net Debt / EBITDA Ratio	-1.65	-3.47	-1.94	-4.43	-1.46	-1.13	Upgrade
Net Debt / FCF Ratio	3.39	2.06	-6.03	-2.76	-1.10	-1.33	Upgrade
Asset Turnover	0.90	1.14	0.75	0.38	0.00	0.04	Upgrade
Inventory Turnover	6.48	7.04	7.82	6.86	1.70	0.48	Upgrade
Quick Ratio	0.10	0.29	0.13	0.34	0.02	0.17	Upgrade
Current Ratio	0.27	0.53	0.22	0.59	0.05	0.19	Upgrade
Return on Equity (ROE)	-314.28%	-	-834.42%	-61.69%	-51.75%	-	Upgrade
Return on Assets (ROA)	-12.75%	-6.80%	-20.62%	-8.11%	-12.08%	-19.33%	Upgrade
Return on Capital Employed (ROCE)	-354.10%	-28.10%	609.40%	-14.00%	-16.90%	86.90%	Upgrade
Earnings Yield	-138235.98%	-44.31%	-87.74%	-16.45%	-5.60%	-35.57%	Upgrade
FCF Yield	48624.58%	34.89%	-13.12%	-10.78%	-4.80%	-20.37%	Upgrade
Buyback Yield / Dilution	-84.15%	-23.47%	26.78%	-29.61%	-156.30%	-80.13%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.